Maravai Lifesciences Holdings (MRVI) Change in Inventory (2020 - 2026)
Maravai Lifesciences Holdings' (MRVI) quarterly Change in Inventory came in at -$33000.0 in Q1 2026, up 92.65% year-on-year from -$17129.5 in Q1 2025, and up 98.93% quarter-over-quarter from -$3.1 million in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Change in Inventory (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Change in Inventory history runs 7 years deep, the most recent figure standing at -$33000.0 for Q1 2026.
- On a quarterly basis, Change in Inventory rose 92.65% year-over-year to -$33000.0 in Q1 2026; TTM through Mar 2026 was -$7.6 million, a 126283.33% decrease from a year earlier, with the FY2025 full-year figure at -$8.0 million, down 2021.75% from the prior year.
- Change in Inventory climbed to -$33000.0 in Q1 2026 per MRVI's latest filing, from -$3.1 million in the prior quarter.
- Across five years, Change in Inventory topped out at $8.7 million in Q2 2022 and bottomed at -$19.3 million in Q4 2022.
- The 5-year median for Change in Inventory is -$452000.0 (2024), against an average of -$1.1 million.
- Across the five-year window, Change in Inventory surged 381.68% in 2023 and plunged 584.07% in 2025, its largest moves.
- Year by year, Change in Inventory stood at -$19.3 million in 2022, then soared by 111.33% to $2.2 million in 2023, then slumped by 120.7% to -$452000.0 in 2024, then plunged by 584.07% to -$3.1 million in 2025, then soared by 98.93% to -$33000.0 in 2026.
- Per Business Quant, the three latest MRVI Change in Inventory figures stand at -$33000.0 (Q1 2026), -$3.1 million (Q4 2025), and -$1.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 1.03 Bn | 1.02 Bn | 33.70 Mn | -33,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33,000.00 |
| Mar 31, 2026 | -33,000.00 |
| Dec 31, 2025 | -3.09 Mn |
| Dec 31, 2025 | -3.09 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Jun 30, 2025 | -3.11 Mn |
| Jun 30, 2025 | -3.11 Mn |
| Mar 31, 2025 | -449,000.00 |
| Mar 31, 2025 | -449,000.00 |
| Dec 31, 2024 | -452,000.00 |
| Dec 31, 2024 | -452,000.00 |
| Sep 30, 2024 | 1.60 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | -702,000.00 |
| Jun 30, 2024 | -702,000.00 |
| Mar 31, 2024 | -820,000.00 |
| Mar 31, 2024 | -820,000.00 |
| Dec 31, 2023 | 2.18 Mn |
| Dec 31, 2023 | 2.18 Mn |